Cargando…

Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity

OBJECTIVE: Pathological destruction of insulin signaling molecules such as insulin receptor substrate, especially due to the increase in suppressors of cytokine signaling molecules, has been demonstrated in experimental diabetes. The contribution of suppressors of cytokine signaling proteins to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Akarsu, Ersin, Sayiner, Zeynel Abidin, Balcı, Sibel Oğuzkan, Demirel, Can, Bozdag, Zehra, Korkmaz, Murat, Yılmaz, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Médica Brasileira 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937604/
https://www.ncbi.nlm.nih.gov/pubmed/36629649
http://dx.doi.org/10.1590/1806-9282.20220856
_version_ 1784890458790428672
author Akarsu, Ersin
Sayiner, Zeynel Abidin
Balcı, Sibel Oğuzkan
Demirel, Can
Bozdag, Zehra
Korkmaz, Murat
Yılmaz, Ibrahim
author_facet Akarsu, Ersin
Sayiner, Zeynel Abidin
Balcı, Sibel Oğuzkan
Demirel, Can
Bozdag, Zehra
Korkmaz, Murat
Yılmaz, Ibrahim
author_sort Akarsu, Ersin
collection PubMed
description OBJECTIVE: Pathological destruction of insulin signaling molecules such as insulin receptor substrate, especially due to the increase in suppressors of cytokine signaling molecules, has been demonstrated in experimental diabetes. The contribution of suppressors of cytokine signaling proteins to the development of insulin resistance and the effects of antidiabetic drugs and exercise on suppressors of cytokine signaling proteins are not clearly known. METHODS: A total of 48 Wistar albino adult male rats were divided into six groups: control group, obese group with diabetes, obese diabetic rats treated with metformin, obese diabetic rats treated with pioglitazone, obese diabetic rats treated with exenatide, and obese diabetic rats with applied exercise program. Immunohistochemical staining was performed in both the liver and adipose tissue. RESULTS: There was a statistically significant decrease in suppressors of cytokine signaling-1, a decrease in suppressors of cytokine signaling-3, an increase in insulin receptor substrate-1, and a decrease in immunohistochemical staining in the obese group treated with metformin and exenatide compared to the obese group without treatment in the liver tissue (p<0.05). A statistically significant decrease in immunohistochemical staining of suppressors of cytokine signaling-1 and suppressors of cytokine signaling-3 was found in the obese group receiving exercise therapy compared to the obese group without treatment in visceral adipose tissue (p<0.05). Likewise, no significant immunohistochemistry staining was seen in diabetic obese groups. CONCLUSION: Metformin or exenatide treatment could prevent the degradation of insulin receptor substrate-1 protein by reducing the effect of suppressors of cytokine signaling-1 and suppressors of cytokine signaling-3 proteins, especially in the liver tissue. In addition, exercise can play a role as a complementary therapy by reducing suppressors of cytokine signaling-1 and suppressors of cytokine signaling-3 proteins in visceral adipose tissue.
format Online
Article
Text
id pubmed-9937604
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Associação Médica Brasileira
record_format MEDLINE/PubMed
spelling pubmed-99376042023-02-18 Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity Akarsu, Ersin Sayiner, Zeynel Abidin Balcı, Sibel Oğuzkan Demirel, Can Bozdag, Zehra Korkmaz, Murat Yılmaz, Ibrahim Rev Assoc Med Bras (1992) Original Article OBJECTIVE: Pathological destruction of insulin signaling molecules such as insulin receptor substrate, especially due to the increase in suppressors of cytokine signaling molecules, has been demonstrated in experimental diabetes. The contribution of suppressors of cytokine signaling proteins to the development of insulin resistance and the effects of antidiabetic drugs and exercise on suppressors of cytokine signaling proteins are not clearly known. METHODS: A total of 48 Wistar albino adult male rats were divided into six groups: control group, obese group with diabetes, obese diabetic rats treated with metformin, obese diabetic rats treated with pioglitazone, obese diabetic rats treated with exenatide, and obese diabetic rats with applied exercise program. Immunohistochemical staining was performed in both the liver and adipose tissue. RESULTS: There was a statistically significant decrease in suppressors of cytokine signaling-1, a decrease in suppressors of cytokine signaling-3, an increase in insulin receptor substrate-1, and a decrease in immunohistochemical staining in the obese group treated with metformin and exenatide compared to the obese group without treatment in the liver tissue (p<0.05). A statistically significant decrease in immunohistochemical staining of suppressors of cytokine signaling-1 and suppressors of cytokine signaling-3 was found in the obese group receiving exercise therapy compared to the obese group without treatment in visceral adipose tissue (p<0.05). Likewise, no significant immunohistochemistry staining was seen in diabetic obese groups. CONCLUSION: Metformin or exenatide treatment could prevent the degradation of insulin receptor substrate-1 protein by reducing the effect of suppressors of cytokine signaling-1 and suppressors of cytokine signaling-3 proteins, especially in the liver tissue. In addition, exercise can play a role as a complementary therapy by reducing suppressors of cytokine signaling-1 and suppressors of cytokine signaling-3 proteins in visceral adipose tissue. Associação Médica Brasileira 2023-01-09 /pmc/articles/PMC9937604/ /pubmed/36629649 http://dx.doi.org/10.1590/1806-9282.20220856 Text en https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Akarsu, Ersin
Sayiner, Zeynel Abidin
Balcı, Sibel Oğuzkan
Demirel, Can
Bozdag, Zehra
Korkmaz, Murat
Yılmaz, Ibrahim
Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
title Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
title_full Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
title_fullStr Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
title_full_unstemmed Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
title_short Effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
title_sort effects of antidiabetics and exercise therapy on suppressors of cytokine signaling-1, suppressors of cytokine signaling-3, and insulin receptor substrate-1 molecules in diabetes and obesity
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9937604/
https://www.ncbi.nlm.nih.gov/pubmed/36629649
http://dx.doi.org/10.1590/1806-9282.20220856
work_keys_str_mv AT akarsuersin effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity
AT sayinerzeynelabidin effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity
AT balcısibeloguzkan effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity
AT demirelcan effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity
AT bozdagzehra effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity
AT korkmazmurat effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity
AT yılmazibrahim effectsofantidiabeticsandexercisetherapyonsuppressorsofcytokinesignaling1suppressorsofcytokinesignaling3andinsulinreceptorsubstrate1moleculesindiabetesandobesity